Presas E, Tovar S, Cuarro J, OShea JP, ODriscoll CM
10.1002/ijc.23131 22 MotzerR
The IRS-1 G972R Polymorphism and Type 2 Diabetes: A Paradigm for the Difficult Ascertainment of the Contribution to Disease Susceptibility of Low Frequency-Low Risk Variants. Nesti, Lorenzo, et al
The right dose is the one that produces results for you, not the one the chart labels as "therapeutic." Microdosing approach For the ultra-conservative, sublingual microdosing starts below the standard initiation dose
Light activity and balanced eating are encouraged to enhance results, but GLP-1s work by addressing hunger and metabolism directly
1 These agents also delay gastric emptying and reduce appetite via central mechanisms, thereby contributing to their metabolic effects